Pharmaceutical compositions for preventing or treating 

angiogenic diseases comprising inhibitors of NUP153 gene expression 

or NUP153 activity as an active ingredient

- Inventor: Prof.Ho Jeong KWON , Yonsei University (kwonhj@yonsei.ac.kr, +82-2-2123-5883)
- Yonsei Technology Holdings Officer: Park Sung Ju/Team Leader (worry1004@yonsei.ac.kr, +82-2-2123-5144)

* Keywords: Angiogenesis, Biotinylated OMe-Syn, NUP153, Macular Degeneration Drug

Thank you for your interest.